ライフサイエンスコーパス: H2 receptor antagonist

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 , and this effect was blocked by a selective H2 receptor antagonist.

2 samples from the patients who were receiving H2 receptor antagonists.

3 ations suggest an immune-enhancing effect of H2-receptor antagonists.

4 Roxatidine, a novel H2 receptor antagonist, acts through a mechanism that in

5 Although use of H2-receptor antagonists (adjusted OR, 1.84; 95% CI, 1.71

6 as lower charges than initial endoscopy when H2-receptor antagonists are used to prevent recurrence o

7 All patients received a histamine-2 (H2)-receptor antagonist-blocking agent during the study.

8 histamine were antagonized by cimetidine, an H2 receptor antagonist, but not by selective H1 and H3 r

9 s from those patients who were not receiving H2 receptor antagonists, but did not change significantl

10 The H2 receptor antagonist cimetidine (2 microM) blocked the

11 Neither the H2 receptor antagonist cimetidine (20 microM) nor the H3

12 ptor antagonist diphenhydramine, whereas the H2 receptor antagonist cimetidine had no effect.

13 Vehicle or the H2 receptor antagonist cimetidine has no effect.

14 t was prevented by treatment with either the H2 receptor antagonist cimetidine or with the potassium

15 As the H2 receptor antagonist cimetidine was perfused to the ti

16 F92374, a structural analog of the histamine H2 receptor antagonist cimetidine, induces antinocicepti

17 an H1 receptor antagonist (pyrilamine) or an H2 receptor antagonist (cimetidine) demonstrated a prote

18 f PPI (n=173,321) and new users of histamine H2-receptor antagonists (H2 blockers; n=20,270) and foll

19 optosis in pre-clinical models and histamine H2 receptor antagonist (H2RA) use may improve symptoms i

20 al indications, we examined associations for H2 receptor antagonists (H2RAs) as a secondary aim.

21 e combination of CCK2/gastrin- and histamine H2-receptor antagonists has synergistic inhibitory effec

22 The histamine H2-receptor antagonists have been identified as inhibito

23 to evaluate whether cimetidine, a histamine H2-receptor antagonist, interferes with the initiation a

24 mys were orally administered an irreversible H2-receptor antagonist loxtidine for 0, 8, and 16 weeks,

25 ceptor antagonist YF476 and/or the histamine H2-receptor antagonist loxtidine for 3 or 6 months.

26 he quad does not have drug interactions with H2-receptor antagonists or proton pump inhibitors, does

27 tor antagonist chlorpheniramine, but not the H2 receptor antagonist ranitidine, blocks the effects of

28 evere thrombocytopenia after exposure to the H2 receptor antagonist, ranitidine, and identified an an

29 ore, SQ29548, a thromboxane A2/prostaglandin H2 receptor antagonist, significantly reduced CD40L-enha

30 sociated with cimetidine and other histamine H2-receptor antagonists, splenectomy, gonorrhea, and bod

31 ever, neither a thromboxane A2/prostaglandin H2 receptor antagonist SQ29548 and a thromboxane synthas

32 Examination of the H2-receptor antagonist structures for insight into the m

33 In the H2 receptor antagonist studies, CVC in control sites was

34 Cimetidine is a powerful H2 receptor antagonist that eliminates histamine's effec

35 As cimetidine is an H2 receptor antagonist, the authors hypothesize that thi

36 rpose of this study was to determine whether H2-receptor antagonist use affects the overall incidence

37 licylate + metronidazole + tetracycline + an H2-receptor antagonist, was supported by two pivotal lit

38 stopped at least 7 days before the study and H2 receptor antagonists were stopped for at least 24 hou

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。